American Physician Partners Leadership

Senior Finance Executive with broad financial and operational experience including - ➢ 17+ years as CFO ➢ 20 years in public accounting➢ IPO and public company operations➢ Multiple equity and debt transactions➢ M&A transactions➢ Private equity ownership and Board interactions➢ Cost transformations and public company transitions➢ Start-up and early stage companies

Andy McQueen are a SVP and Chief Development Officer at AMERICAN PHYSICIAN PARTNERS and are based in Nashville, Tennessee. They have worked as Member at Bass Berry & Sims, Partner at Bass Berry & Sims, and Chief Legal Officer at AMERICAN PHYSICIAN PARTNERS. Andy studied at University of Texas School of Law between 1998 and 2001, University of Texas System, and Lipscomb University between 1991 and 1995.

Experienced Leader in IT for the Healthcare industry with a strong background as a data architect and software engineer

Tony presently serves as SVP and Chief Medical Officer for American Physician Partners where he oversees all of the company’s clinical initiatives, including champions for sepsis, stroke recognition and opiate prescribing. He is also responsible for developing the APP Leadership Academy and plays an active role in the business development and client management process. Tony served as President & Chief Medical Officer for AlignMD, a predecessor to American Physician Partners, and was the Executive Medical Director for Emergency Medicine Services at Sparrow Health System. He played football while earning his Bachelor of Science in Physiology at Michigan State University then earned his Doctor of Medicine at Georgetown University School of Medicine. Tony is board certified in Emergency Medicine.

Senior Finance Executive with broad financial and operational experience including - ➢ 17+ years as CFO ➢ 20 years in public accounting➢ IPO and public company operations➢ Multiple equity and debt transactions➢ M&A transactions➢ Private equity ownership and Board interactions➢ Cost transformations and public company transitions➢ Start-up and early stage companies